Shuiliang Wang Selected Research

Shuiliang Wang Research Topics

Disease

17	Neoplasms (Cancer) 01/2021 - 11/2009
7	Breast Neoplasms (Breast Cancer) 01/2018 - 11/2009
4	Multiple Myeloma 07/2013 - 10/2010
3	Renal Cell Carcinoma (Grawitz Tumor) 04/2020 - 01/2019
3	Carcinoma (Carcinomatosis) 12/2019 - 11/2018
3	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 08/2005
2	Adenocarcinoma of Lung 04/2020 - 12/2019
2	Lung Neoplasms (Lung Cancer) 04/2020 - 12/2019
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 06/2016
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2013 - 06/2011
2	Hairy Cell Leukemia 01/2013 - 06/2011
1	Obesity 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Renal Insufficiency (Renal Failure) 04/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 12/2019
1	Colorectal Neoplasms (Colorectal Cancer) 11/2019
1	Crohn Disease (Crohn's Disease) 11/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2019
1	Carcinogenesis 11/2018
1	Osteoarthritis 10/2017
1	Triple Negative Breast Neoplasms 01/2012
1	Congenital Methemoglobinemia 08/2008

Drug/Important Bio-Agent (IBA)

7	MicroRNAs (MicroRNA)IBA 01/2020 - 06/2016
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 01/2013
4	SurvivinIBA 01/2018 - 01/2013
3	Proteins (Proteins, Gene)FDA Link 04/2020 - 01/2017
3	Messenger RNA (mRNA)IBA 11/2018 - 08/2008
3	Trastuzumab (Herceptin)FDA Link 11/2013 - 02/2010
3	entinostat (MS 275)IBA 07/2013 - 11/2009
2	Pharmaceutical PreparationsIBA 04/2020 - 02/2010
2	Biological ProductsIBA 11/2019 - 08/2008
2	RNA (Ribonucleic Acid)IBA 01/2019 - 11/2018
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 01/2012
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 11/2018
2	seribantumabIBA 11/2013 - 01/2013
2	IGF Type 1 Receptor (IGF 1 Receptor)IBA 11/2013 - 02/2010
2	Caspase 3 (Caspase-3)IBA 11/2013 - 08/2011
2	Histone Deacetylases (Histone Deacetylase)IBA 07/2013 - 11/2009
2	Bendamustine Hydrochloride FDA Link 07/2013 - 01/2013
2	Cladribine FDA LinkGeneric 01/2013 - 06/2011
2	Purine NucleosidesIBA 01/2013 - 06/2011
2	Histone Deacetylase InhibitorsIBA 08/2011 - 11/2009
2	Growth Factor ReceptorsIBA 02/2010 - 11/2009
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	NeuregulinsIBA 01/2021
1	Amylases FDA Link 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 04/2020
1	pazopanib FDA Link 04/2020
1	hesperetinIBA 04/2020
1	Vitamin D3 24-HydroxylaseIBA 01/2020
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020
1	Vitamin D FDA LinkGeneric 01/2020
1	hydroxide ionIBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	icariinIBA 12/2019
1	DAPIIBA 12/2019
1	Triglycerides (Triacylglycerol)IBA 11/2019
1	Valproic Acid (Depakote)FDA LinkGeneric 04/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2019
1	guanosine 5'-monophosphorothioateIBA 01/2019
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2019
1	Long Noncoding RNAIBA 11/2018
1	Competitive Endogenous RNAIBA 11/2018
1	Neuregulin-1 (Neuregulin 1)IBA 01/2018
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2018
1	Conditioned Culture MediaIBA 01/2018
1	Mitogen-Activated Protein KinasesIBA 10/2017
1	PapainIBA 10/2017
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2017
1	Eukaryotic Initiation Factor-2 (EIF 2)IBA 01/2017
1	glucose-regulated proteinsIBA 01/2017
1	TunicamycinIBA 01/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2013
1	Estrogen ReceptorsIBA 01/2012
1	Metformin (Glucophage)FDA LinkGeneric 01/2012
1	ErbB Receptors (EGF Receptor)IBA 01/2012
1	Alkylating AgentsIBA 10/2010
1	Protein Isoforms (Isoforms)IBA 11/2009
1	antibiotic G 418IBA 08/2008
1	Small Interfering RNA (siRNA)IBA 08/2008
1	LipofectamineIBA 08/2008
1	A-Form DNA (A-DNA)IBA 08/2005

Therapy/Procedure

7	Therapeutics 01/2020 - 11/2009
1	Salvage Therapy 04/2020
1	Drug Therapy (Chemotherapy) 04/2020
1	Transplantation 01/2020